Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Towne Bank (TOWN)

Towne Bank (TOWN)
12.26 x 2 43.59 x 9
Pre-market by (Cboe BZX)
30.64 -0.12 (-0.39%) 04/11/25 [NASDAQ]
12.26 x 2 43.59 x 9
Pre-market 30.64 unch (unch) 16:00 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
29.89
Day High
30.78
Open 30.45
Previous Close 30.76 30.76
Volume 362,900 362,900
Avg Vol 344,015 344,015
Stochastic %K 25.48% 25.48%
Weighted Alpha +5.36 +5.36
5-Day Change +0.03 (+0.10%) +0.03 (+0.10%)
52-Week Range 25.70 - 38.28 25.70 - 38.28
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,298,030
  • Shares Outstanding, K 75,001
  • Annual Sales, $ 1,026 M
  • Annual Income, $ 161,760 K
  • EBIT $ 217 M
  • EBITDA $ 256 M
  • 60-Month Beta 0.79
  • Price/Sales 2.25
  • Price/Cash Flow 11.36
  • Price/Book 1.07

Options Overview Details

View History
  • Implied Volatility 71.33% ( +1.01%)
  • Historical Volatility 35.66%
  • IV Percentile 95%
  • IV Rank 83.33%
  • IV High 82.11% on 07/05/24
  • IV Low 17.46% on 07/19/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 5
  • Volume Avg (30-Day) 21
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 199
  • Open Int (30-Day) 209

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.61
  • Number of Estimates 1
  • High Estimate 0.61
  • Low Estimate 0.61
  • Prior Year 0.48
  • Growth Rate Est. (year over year) +27.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.43 +4.11%
on 04/09/25
Period Open: 33.75
35.63 -14.01%
on 03/26/25
-3.11 (-9.21%)
since 03/11/25
3-Month
29.43 +4.11%
on 04/09/25
Period Open: 32.13
38.01 -19.39%
on 02/19/25
-1.49 (-4.64%)
since 01/10/25
52-Week
25.70 +19.22%
on 06/11/24
Period Open: 26.45
38.28 -19.96%
on 12/05/24
+4.19 (+15.84%)
since 04/11/24

Most Recent Stories

More News
TowneBank and Old Point Financial Corporation Announce Agreement to Merge

TOWN : 30.64 (-0.39%)
OPOF : 36.75 (-0.38%)
TowneBank Announces Completion of Village Bank and Trust Financial Corp. Merger

TOWN : 30.64 (-0.39%)
TowneBank and Village Bank and Trust Financial Corp. Receive Regulatory Approvals for Merger

VBFC : 80.21 (+0.01%)
TOWN : 30.64 (-0.39%)
TowneBank Announces Quarterly Cash Dividend

TOWN : 30.64 (-0.39%)
TowneBank: Q4 Earnings Snapshot

TowneBank: Q4 Earnings Snapshot

TOWN : 30.64 (-0.39%)
TowneBank Reports Full Year and Fourth Quarter Financial Results for 2024

TOWN : 30.64 (-0.39%)
TowneBank Declares Fourth-Quarter Cash Dividend of $0.25 per Share

TowneBank declared a $0.25 fourth-quarter dividend, payable January 14, 2025, to shareholders of record on December 31, 2024.Quiver AI SummaryTowneBank, based in Hampton Roads, Virginia, has declared a...

TOWN : 30.64 (-0.39%)
TowneBank Announces Quarterly Cash Dividend

TOWN : 30.64 (-0.39%)
TowneBank: Q3 Earnings Snapshot

TowneBank: Q3 Earnings Snapshot

TOWN : 30.64 (-0.39%)
TowneBank Reports Third Quarter 2024 Earnings

TOWN : 30.64 (-0.39%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds MMAC, SBBP, HRVSF, and XOG Shareholders About Its Ongoing Investigations

NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) --

MMAC : 27.77 (+0.04%)
SBBP : 2.00 (+1.52%)
HRVSF : 3.2200 (+0.94%)
XOG : 68.54 (+2.87%)
Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing’s Syndrome

DUBLIN, Ireland and TREVOSE, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization...

SBBP : 2.00 (+1.52%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CORE, COG, ARPO, SBBP; Shareholders are Encouraged to Contact the Firm

NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CORE : 45.65 (-0.76%)
COG : 22.25 (+2.25%)
ARPO : 2.20 (-0.90%)
SBBP : 2.00 (+1.52%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds XEC, MMAC, SBBP, and HRVSF Shareholders About Its Ongoing Investigations

NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) --

XEC : 87.20 (-3.11%)
MMAC : 27.77 (+0.04%)
SBBP : 2.00 (+1.52%)
HRVSF : 3.2200 (+0.94%)
STRONGBRIDGE BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Strongbridge Biopharma plc - SBBP

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Strongbridge Biopharma plc (NasdaqGS: SBBP)...

SBBP : 2.00 (+1.52%)
XERS : 4.16 (+5.32%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Strongbridge Biopharma plc Merger

WILMINGTON, Del., May 25, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Strongbridge Biopharma plc (“Strongbridge”) (NASDAQ GS: SBBP ) regarding possible breaches...

SBBP : 2.00 (+1.52%)
XERS : 4.16 (+5.32%)
Strongbridge Biopharma Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Strongbridge Biopharma plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – SBBP

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Strongbridge Biopharma plc (NASDAQ: SBBP) to Xeris Pharmaceuticals, Inc. is fair to Strongbridge shareholders....

SBBP : 2.00 (+1.52%)
STRONGBRIDGE BIOPHARMA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of SBBP and Encourages Investors to Contact the Firm

NEW YORK, May 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Strongbridge...

SBBP : 2.00 (+1.52%)
XERS : 4.16 (+5.32%)
Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases

Xeris Pharmaceuticals, Inc. (“Xeris”) (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable drug formulations,...

SBBP : 2.00 (+1.52%)
XERS : 4.16 (+5.32%)
Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma Plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable drug formulations, and Strongbridge...

XERS : 4.16 (+5.32%)
SBBP : 2.00 (+1.52%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds MMAC, SBBP, HRVSF, and XOG Shareholders About Its Ongoing Investigations

NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) --

MMAC : 27.77 (+0.04%)
SBBP : 2.00 (+1.52%)
HRVSF : 3.2200 (+0.94%)
XOG : 68.54 (+2.87%)
Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing’s Syndrome

DUBLIN, Ireland and TREVOSE, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization...

SBBP : 2.00 (+1.52%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CORE, COG, ARPO, SBBP; Shareholders are Encouraged to Contact the Firm

NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CORE : 45.65 (-0.76%)
COG : 22.25 (+2.25%)
ARPO : 2.20 (-0.90%)
SBBP : 2.00 (+1.52%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds XEC, MMAC, SBBP, and HRVSF Shareholders About Its Ongoing Investigations

NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) --

XEC : 87.20 (-3.11%)
MMAC : 27.77 (+0.04%)
SBBP : 2.00 (+1.52%)
HRVSF : 3.2200 (+0.94%)
STRONGBRIDGE BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Strongbridge Biopharma plc - SBBP

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Strongbridge Biopharma plc (NasdaqGS: SBBP)...

SBBP : 2.00 (+1.52%)
XERS : 4.16 (+5.32%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Strongbridge Biopharma plc Merger

WILMINGTON, Del., May 25, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Strongbridge Biopharma plc (“Strongbridge”) (NASDAQ GS: SBBP ) regarding possible breaches...

SBBP : 2.00 (+1.52%)
XERS : 4.16 (+5.32%)
Strongbridge Biopharma Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Strongbridge Biopharma plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – SBBP

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Strongbridge Biopharma plc (NASDAQ: SBBP) to Xeris Pharmaceuticals, Inc. is fair to Strongbridge shareholders....

SBBP : 2.00 (+1.52%)
STRONGBRIDGE BIOPHARMA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of SBBP and Encourages Investors to Contact the Firm

NEW YORK, May 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Strongbridge...

SBBP : 2.00 (+1.52%)
XERS : 4.16 (+5.32%)
Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases

Xeris Pharmaceuticals, Inc. (“Xeris”) (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable drug formulations,...

SBBP : 2.00 (+1.52%)
XERS : 4.16 (+5.32%)
Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma Plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable drug formulations, and Strongbridge...

XERS : 4.16 (+5.32%)
SBBP : 2.00 (+1.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

TowneBank operates banking offices serving Chesapeake, Chesterfield County, Glen Allen, Hampton, James City County, Mechanicsville, Newport News, Norfolk, Portsmouth, Richmond, Suffolk, Virginia Beach, Williamsburg, and York County in Virginia, along with Raleigh, Cary, Charlotte, Moyock, Grandy, Camden...

See More

Key Turning Points

3rd Resistance Point 31.88
2nd Resistance Point 31.33
1st Resistance Point 30.99
Last Price 30.64
1st Support Level 30.09
2nd Support Level 29.54
3rd Support Level 29.20

See More

52-Week High 38.28
Fibonacci 61.8% 33.47
Fibonacci 50% 31.99
Last Price 30.64
Fibonacci 38.2% 30.51
52-Week Low 25.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.